Income Statement

ADVANCED BIOMED INC.

ADVB
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Jun 30, 2025 2025 FY
Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expenses
3.02
Research & Development
0.91
Selling, General & Administrative
2.11
Other Operating Expenses
-
Operating Income
-3.02
Non-Operating Income
-0.24
Interest Income
0.02
Interest Expense
-
Other Non-Op Income / Expense
-0.26
Income Before Tax
-3.26
Income Tax Expense
0.00
Non-Controlling Interest
-
Net Income
-3.26
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Jun 30, 2025 2025 FY
Depreciation & Amortization
-
EBITDA
-2.68
Earnings Per Share (Basic)
-0.16
Diluted EPS
-0.16
Weighted Average Shares
20.53
Diluted Weighted Avg Shares
20.53
Comprehensive Income
-3.04